AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.
Based on 784 businesses audited.
Genentech has 32.7 points less BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: Genentech (herceptin.com)
This site is a rare example of a 0% fluff marketing environment. It prioritizes the clinical and regulatory reality of the medicine over brand-building air, resulting in a nearly non-existent BS score.
Refresh clinical citations to post-2023 versions where available to eliminate stale-date penalties. Reduce the repetitive use of the Journey brand metaphor in H1 tags to improve heading substance. Implement Person schema for medical reviewers of the patient-facing content to bridge the minor authority footprint gap. Ensure all external links to FDA and NEJM PDFs are current and not 404-prone.
Information density is exceptionally high, with body text dominated by specific nouns and technical protocols such as AC-TH and TCH treatment courses. Headings like HEART PROBLEMS and SEVERE LUNG PROBLEMS lead directly to substantiating text rather than power-word fluff. The ratio of clinical data to marketing language is approximately 8:1, with only minor points lost for the repetitive Journey metaphor.
AI does not see your layout — it sees your DOM. Get a Clinical Semantic Structure Diagnosis to reveal how your page is segmented, weighted, and interpreted.
There is zero drift between the homepage promises and sub-page delivery. The homepage H1 regarding Uses & Important Safety Information is precisely what the sub-pages deliver in exhaustive detail. Whether a user clicks into Early Breast Cancer or Metastatic Breast Cancer, the clinical specificity remains consistent with the primary signal.
Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.
No trust theatre was detected. The review_count is 0 across all pages, showing an avoidance of unverified social proof. Instead, the site uses verified proof paths, linking directly to NEJM studies, ClinicalTrials.gov identifiers (NCT00004067), and FDA approval letters from 1998.
The proof density is among the highest in the industry. Verifiable evidence (clinical trial IDs, NEJM citations, FDA approval dates) outnumbers vague assertions by a ratio of 10:1. The site provides actual URLs to accessdata.fda.gov and nejm.org, creating clear external validation paths.
To examine how structural entropy affects chunking and retrieval, review the Moz Semantic HTML audit. View the Moz Semantic HTML Audit for a complete example of heading logic, landmark integrity, and DOM depth diagnostics.
The site avoids generic value propositions, as its content is molecularly specific to trastuzumab. While it uses template-style sections like About Us and For Healthcare Professionals, the body text within these sections contains unique prescribing information that could not be applied to a competitor drug without fundamental clinical errors.
Authority is robustly established through Organization schema for Genentech and the inclusion of high-authority external citations. While the NCCN Guideline citations (2019) are stale relative to the 2026 system date, they represent legitimate medical authority footprints rather than manufactured expertise.
Marketing tone is almost entirely suppressed by regulatory necessity. Every performance claim, such as the 2.4 million people worldwide taken the Herceptin journey, is moderated by footnotes explaining the calculation methodology and extensive lists of potential serious side effects.
Medical Devices, Pharma & Biotech BS: Genentech (herceptin.com)
The website perfectly aligns with the Pharma & Biotech category. It serves as a regulatory-compliant product portal for Herceptin (trastuzumab), focusing heavily on indications, safety data, and clinical trial references.
AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.
“The score was primarily driven by minor commodity fingerprint cliches (the 'Journey' branding) and concept repetition necessitated by ISI requirements. The Trust and Proof pillar received a negligible penalty for stale 2019 citations, while Information Density and Semantic Coherence scored near-perfectly due to extreme clinical specificity.”
Analysis Disclosure & Source Attribution
Snapshot Date: May 30, 2026
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to see how machine logic interprets digital signals.
Machine Perception Notice: This evaluation is generated by machine-read logic (MRL). The AI interprets the “Digital Ghost” of a website (code, metadata, and semantic structures), which may differ from what a human sees at the same moment. This is an automated technical diagnostic and not a statement of fact or human opinion regarding the real-world integrity or legitimacy of the business. Any missing or inaccessible elements in the snapshot are treated as machine-read signals, reflecting AI rendering limitations rather than intentional omission.
Notice to the Evaluated Business: This analysis is part of a non-adversarial audit. The results are intended as professional feedback to help improve machine-readability and authority signals. Any company can use these insights for free. When content is updated, a fresh audit can be requested at any time to reflect the current state.
To All Users: You are encouraged to visit the live site at Genentech to view the most current version of their content and see directly what the company offers.